Canaan Partners XI LLC - Q4 2022 holdings

$127 Million is the total value of Canaan Partners XI LLC's 5 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .

 Value Shares↓ Weighting
DAWN SellDAY ONE BIOPHARHACEUTICALS I$54,841,633
-60.7%
2,548,403
-63.4%
43.06%
-23.5%
 TYRA BIOSCIENCES INC$33,515,932
-13.5%
4,409,9910.0%26.32%
+68.3%
AEVA  AEVA TECHNOLOGIES INC$25,139,868
-27.3%
18,485,1970.0%19.74%
+41.6%
SellRALLYBIO CORP$13,532,308
-61.2%
2,059,712
-14.5%
10.63%
-24.4%
VECT  VECTIVBIO HLDG AG$320,862
+44.5%
37,0510.0%0.25%
+180.0%
SellBIRD GLOBAL INC$0
-100.0%
0
-100.0%
0.00%
-100.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-01
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
DAY ONE BIOPHARMACEUTICALS I8Q3 202361.6%
TYRA BIOSCIENCES INC8Q3 202353.3%
AEVA TECHNOLOGIES INC8Q3 202336.0%
RALLYBIO CORP8Q3 202314.1%
VECTIVBIO HLDG AG7Q2 20230.3%
BIRD GLOBAL INC5Q4 20220.1%
MONEYLION INC1Q3 20231.4%
MONEYLION INC1Q2 20230.6%

View Canaan Partners XI LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-01
13F-HR2023-10-11
13F-HR2023-07-13
13F-HR2023-04-06
13F-HR2023-02-01
13F-HR2022-10-31
42022-09-22
42022-09-20
42022-09-15
13F-HR2022-08-10

View Canaan Partners XI LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported number of holdings is incorrect (5 != 6)

Export Canaan Partners XI LLC's holdings